Active Biotech AB (OSTO:ACTI) Total Liabilities : kr10.44 Mil (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Active Biotech AB Total Liabilities?

Active Biotech AB's Total Liabilities for the quarter that ended in Dec. 2024 was kr10.44 Mil.

Active Biotech AB's quarterly Total Liabilities increased from Jun. 2024 (kr12.50 Mil) to Sep. 2024 (kr13.50 Mil) but then declined from Sep. 2024 (kr13.50 Mil) to Dec. 2024 (kr10.44 Mil).

Active Biotech AB's annual Total Liabilities declined from Dec. 2022 (kr16.49 Mil) to Dec. 2023 (kr13.38 Mil) and declined from Dec. 2023 (kr13.38 Mil) to Dec. 2024 (kr10.44 Mil).

Active Biotech AB Total Liabilities Historical Data

The historical data trend for Active Biotech AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Total Liabilities Chart

Active Biotech AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

10.04

10.13

16.49

13.38

10.44

Active Biotech AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															13.38	13.50	12.50	13.50	10.44

Active Biotech AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Active Biotech AB's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8.908	+	(1.533	+	1.3322676295502E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	10.44

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	43.184	-	32.743
	=	10.44

Active Biotech AB's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8.908	+	(1.533	+	1.3322676295502E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	10.44

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	43.184	-	32.743
	=	10.44

Active Biotech AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Active Biotech AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Active Biotech AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (OSTO:ACTI) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

0GQU:UK BTPC:Germany

Address

Scheelevagen 22, P.O. Box 724, Lund, SWE, 223 63

Website

https://www.activebiotech.com

Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB Headlines

No Headlines